Danbee Kang

Effects of Body-Weight Changes on the Risk of New-Onset Diabetes in Individuals With Non-Diabetic Metabolic Dysfunction-Associated Steatotic Liver Disease

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of hepatic and extrahepatic complications.Although weight reduction is the primary recommended intervention, its impact on extrahepatic outcomes remains uncertain.We...